A randomized trial to assess functional and structural effects of ranibizumab versus laser in diabetic macular edema (the LUCIDATE study).
一项随机试验来评估治疗对糖尿病性黄斑水肿激光功能及结构的影响(的lucidate研究)。
2
The CATT data support the continued global use of intravitreal bevacizumab as an effective. low-cost alternative to ranibizumab, particularly for patients paying all costs out of pocket.